1. Home
  2. |Insights
  3. |DEAL NOTE: Crowell & Moring Advises BayWa Venture GmbH in YoFix Probiotics Investment

DEAL NOTE: Crowell & Moring Advises BayWa Venture GmbH in YoFix Probiotics Investment

Firm News | less than 1 min read | 12.06.21

San Francisco – December 6, 2021: Crowell & Moring represented BayWa Venture GmbH, the investment and collaboration arm of BayWa AG (BYW:Xetra) in its investment in the Israeli start-up YoFix Probiotics’ $3.5 million second financing round.  YoFix Probiotics produces alternatives to milk and dairy products such as yogurt and porridge, using oats, lentils, sunflower seeds, sesame and coconut in place of milk.  YoFix Probiotics is BayWa Venture’s third investment in the field of alternative proteins so far this year.  The transaction was led by senior counsel Mark Kass (Washington) with support from partner Jon O’Connell (San Francisco) and counsel Matt Pelnar (San Francisco).

Insights

Firm News | 2 min read | 05.22.26

Crowell & Moring Represents Kanders & Company in Acquisition of Ginkgo Bioworks’ Biosecurity Business

May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF)....